loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 209830 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ALKERMES INC (1)

filter

01 SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR (1)

filter

01 RX (1)

filter

01 ARISTADA INITIO KIT (1)

filter

01 Yes (1)

URL Supplier Web Content
SUSPENSION, EXTEND...
675MG/2.4ML (281.2...
2018-06-29
209830
ARISTADA INITIO KI...
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 209830

Looking for FDA Orange Book APPLICATION 209830 1

19

Alkermes Plc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ARIPIPRAZOLE LAUROXIL, with a corresponding application number 209830.

Regulatory Information RX

With a dosage strength 675MG/2.4ML (281.25MG/ML)

Dosage Form Route SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR

Reference Listed Drug Yes

Approved since 2018-06-29

Post Enquiry
POST ENQUIRY